NCT03738358View on ClinicalTrials.gov

Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 20, 2018

Study Completion Date

March 20, 2018

Conditions
Non-alcoholic Fatty Liver
Interventions
DIETARY_SUPPLEMENT

Trehalose

80 mL pouch/day for 12 weeks, containing trehalose 5 g, water 74.92 g and scent additive 0.08 g

OTHER

Placebo

80 mL pouch/day for 12 weeks, containing water 79.92 g and scent additive 0.08 g

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03738358 - Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease | Biotech Hunter | Biotech Hunter